# Antilipidemic Ezetimibe Induces Regression of Endometriotic Explants in a Rat Model of Endometriosis

> **NCT04844996** · EARLY_PHASE1 · COMPLETED · sponsor: **Mersin University** · enrollment: 18 (actual)

## Conditions studied

- Endometriosis

## Interventions

- **PROCEDURE:** Surgical induction of endometriotic explants

## Key facts

- **NCT ID:** NCT04844996
- **Lead sponsor:** Mersin University
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-09-01
- **Primary completion:** 2019-12-01
- **Final completion:** 2021-01-31
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2021-04-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04844996

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04844996, "Antilipidemic Ezetimibe Induces Regression of Endometriotic Explants in a Rat Model of Endometriosis". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT04844996. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*